title: [Hope and limits in cell therapies].
abstract: The hematopoietic system is one of the best characterized human cellular system in which a multipotent adult stem cell is at the origin of all the cells of a tissue. These last years, the use of stem cells has given rise to many hopes in regenerative medicine, especially in diseases without efficient therapies. However the hematopoietic system in which stem cell transplantation has entered in clinical practice for many years has also shown the limits of these approaches. Especially the in vitro manipulation of hematopoietic stem cells remains a challenge which requires more fundamental knowledge on the biology of stem cells including self renewal and homing. Knowledge for other tissue system is even more preliminary but the same experimental strategy used for hematopoietic stem cell can be translated and may accelerate their use in cell therapies. Characterization of human adult pluripotent stem cells and the generation of human ES cells capable to differentiate towards several tissues have led to new hopes but the road to their use in therapies may be long and will require a lot of investment in basic biology.
authors.affiliation: Inserm U 362, IFR 54, Institut Gustave-Roussy, PR1, Villejuif, France.
authors.forename: A
authors.initials: A
authors.lastname: Bennaceur-Griscelli
authors.forename: W
authors.initials: W
authors.lastname: Vainchenker
mesh_terms: D000328:Adult; D002454:Cell Differentiation / Q000187:drug effects; D019070:Cell Lineage; D064987:Cell- and Tissue-Based Therapy / Q000379:methods / Q000639:trends; D002478:Cells, Cultured / Q000187:drug effects / Q000637:transplantation; D016207:Cytokines / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D033581:Stem Cell Transplantation / Q000379:methods
chemical_list: D016207:Cytokines; D006133:Growth Substances